Blog - Page 1230 of 5708

WednesdaySep 01, 2021 11:44 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc.’s (NASDAQ: WTER) (CSE: WTER) Alkaline88(R) Coming Soon to 9 Major US Airports

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today announced that its one-liter and 700ml bottles of Alkaline88(R) will be available in over 100 retail locations in nine major U.S. airports. “With the rebounding of the airline industry, this was an ideal time for Alkaline88 to enter into this channel. The sales team and our new director of hospitality and foodservice, Gary Bliss, have done an amazing job securing this deal. Now, hundreds of millions of passengers will have access to Deliciously Smooth(TM) Alkaline88 as they travel through…

WednesdaySep 01, 2021 11:36 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) Announces Meet Delic Keynote Speaker

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, has revealed the keynote speaker for its upcoming Meet Delic event. Renowned shaman and best-selling author Alyson Charles will speak at the two-day immersive edutainment experience that is designed as an elite gathering for the world's leading psychedelic and wellness thought and business leaders. The event is scheduled for Nov. 6–7, 2021, and will be an in-person gathering at AREA15 in Las Vegas, Nevada. In her keynote address, titled “Surrender & Integration: Creating Soul and Plant Spirit Alignment to Master the Journey,” Charles will share how to connect to…

WednesdaySep 01, 2021 11:27 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at H.C. Wainwright Global Investment Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, today announced that it will present at the H.C. Wainwright Annual Global Investment Conference. The event is slated to be held virtually on Sept. 13-15, 2021. Greg McKee, chairman and CEO of Tryp, will provide an overview of the company and its pipeline including Tryp's Psilocybin-for-Neuropsychiatric Disorders (“PFN”(TM)) program for chronic pain and eating disorder indications. Interested parties should visit https://ibn.fm/AkhYM to register and access the presentation. In addition, Tryp announced that it has granted an…

WednesdaySep 01, 2021 11:11 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targets Burgeoning Hypertension, Antiviral Therapeutics Markets with Drug Delivery Technology

Lexaria has progressed significantly in evidencing that its patented DehydraTECH(TM) drug delivery technology can sufficiently improve the usable fraction of known antiviral drugs that reach the bloodstream According to a Newsfile Corp. article, this technology can be applied to rendering treatments for HIV/AIDS and other infectious diseases more effective The company also released partial results from a human clinical study evaluating DehydraTECH-processed CBD for potential application against hypertension, which evidenced a rapid and sustained drop in blood pressure Growing hypertension and antiviral therapeutics market represent a potential win for Lexaria In July, Lexaria Bioscience (NASDAQ: LEXX), a drug delivery technology…

WednesdaySep 01, 2021 10:55 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Launches Redesigned Canadian Website on Shopify

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of its redesigned Canadian website www.PlantX.ca, powered by Shopify. The new website features a refreshed and modern design, simplified navigation and upgraded search tools and functionality to enhance overall user experience and brand impact. “The decision to transition to Shopify as the main e-commerce platform to host the PlantX online presence is a strategic move that complements the company's mission and expansion plans,” said PlantX Founder Sean Dollinger. “By leveraging the Shopify embedded features, PlantX will be able to replicate its current Canadian model and launch additional websites…

WednesdaySep 01, 2021 10:34 am

InnerScope Hearing Technologies Inc. (INND) Poised for Growth as Prevalence of Hearing Loss Could Increase Amid Aging Society

Hearing loss affects a considerable number of older adults; one-third of 65-year-olds and half of 75-year-olds suffer from some hearing impairment In an increasingly aging society, this could quickly become a public health problem as it is associated with high societal and healthcare costs INND continues to disrupt hearing healthcare; committed to providing game-changing hearing technology in a potentially growing market for hearing aids InnerScope’s launches its hearing aids on FSAstore.com, HSAstore.com, and WellDeservedHealth.com consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HSA”), and employers’ health incentive programs InnerScope Hearing Technologies (OTC: INND), a hearing health technology company…

WednesdaySep 01, 2021 9:59 am

With a Focus On AI and ML Technology, Brain Scientific Inc. (BRSF) Is Positioned to Take The Lead in Growing EEG Market

Brain Scientific focused on leveraging AI and ML to detect neurological diseases, aims to create comprehensive database of brain biomarkers to increase diagnosis accuracy Brain Scientific positioned to disrupt EEG market with FDA-cleared patented products that provide cost-effective brain imaging in any setting Current global EEG device market estimated at $956.1 million with CAGR of 8.7% from 2019 to 2026, expected to reach $1.6 billion by 2026 With more industries embracing artificial intelligence (“AI”) and machine learning (“ML”) than ever before, Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, is ahead of the curve in the neurology market with its…

WednesdaySep 01, 2021 9:55 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports on Milestone Achievements Reached by Subsidiary

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has announced that Adelia Therapeutics Inc., its wholly controlled subsidiary, has reached key milestones for Year 1 Q3. The milestones were outlined in last year’s transaction agreement between Cybin, Cybin Corp., Cybin US Holdings Inc. and previous shareholders of Adelia. Based on the agreement, 9,392.6 Class B common shares in the capital of Cybin will be issued to Adelia shareholders; the issuance is designed to satisfy the approximately $251,581.81 owed to the shareholders upon Adelia meeting the outlined milestones. The announcement noted that the Class B shares…

TuesdayAug 31, 2021 1:57 pm

Microdose Psychedelic Insight’s DMT Conference set to take place on September 9-10th, 2021

Microdose Psychedelic Insights will host the upcoming DMT Conference on September 9-10th, 2021 Part of a series of deep dive events looking into various psychoactive and psychedelic substances, the DMT conference will examine the potential of DMT within today’s society The conference will play host to a number of keynote presentations and discussions delivered by some of the industry’s leading thinkers and innovators Microdose Psychedelic Insights (“Microdose”) is set to host their virtual DMT Conference on September 9-10th, 2021. The event will serve as a deep dive into the dynamic field of DMT therapeutics, featuring a number of expert panels…

TuesdayAug 31, 2021 1:40 pm

FingerMotion Inc. (FNGR) Shares Progress on the NASDAQ Uplisting Application, Big Data Insights Division, in its August Corporate Update

On August 25, FingerMotion held a conference call in which it provided updates on the progress of its Sapientus division, application to uplist to the NASDAQ, and more Hosted by FingerMotion CEO Martin Shen, the corporate update also included a review of the Q1 2022 results, which marked the fourth consecutive quarter of record revenue FingerMotion received its first comment letter from NASDAQ, to which it responded promptly and efficiently The company, in collaboration with its partners, has begun translating products under the Sapientus division into an actual operational pilot FNGR will hold an AGM in November In July last…

Site Search

Company Search